ABSTRACT
, and to assess the validity of established upper normal limits for physiological cardiac hypertrophy. Results There was strong linear relationship between BSA and LV dimensions; yet no athlete with a normal ECG presented a maximal wall thickness and LVIDd greater than 13 and 65 mm, respectively. In Group 3 athletes, Black African ethnicity was associated with larger cardiac dimensions than either Caucasian or West Asian ethnicity. Three athletes were diagnosed with a cardiomyopathy (0.4% prevalence); with two athletes presenting a maximal wall thickness >13 mm, but in combination with an abnormal ECG suspicious of an inherited cardiac disease. Conclusion Regardless of extreme anthropometry, established upper limits for physiological cardiac hypertrophy of 14 mm for maximal wall thickness and 65 mm for LVIDd are clinically appropriate for all athletes. However, the abnormal ECG is key to diagnosis and guides follow-up, particularly when cardiac dimensions are within accepted limits.
INTRODUCTION
Regular and prolonged intensive exercise is associated with cardiac morphological adaptation, together with electrocardiographic alterations. [1] [2] [3] [4] Significant cardiac enlargement may be an expression of underlying cardiac disease, placing the athlete at a greater risk of sudden cardiac death (SCD). 5 In rare cases, the degree of physiological adaptation in cardiac morphology can mimic that of a number of pathological disease states, most notably hypertrophic cardiomyopathy (HCM). 6 Differentiation between a physiological or pathological remodelling process is, therefore, extremely important. Consequently, establishing the upper normal limits of physiological enlargement in response to physical training is an important focus for clinicians and scientists.
Fourteen and 65 mm have been established as the physiological upper limits for maximal wall thickness and left ventricular (LV) internal diameter during diastole, respectively. These limits come from three large-scale studies examining approximately 4800 elite athletes ( predominantly male), who observed that a small minority (1.5-4%) demonstrate LV hypertrophy (LVH) >13 mm and 4-6% have an LV end-diastolic dimension >60 mm. What this minority of athletes with pronounced LVH have common is an enlarged BSA (approximate mean BSA 2.1 m 2 ). 4 7 8 However, despite recognising that the largest maximal wall thicknesses are observed in those with the largest BSA's, there are limited data examining the impact of extreme body anthropometry (BSA>2.3 m 2 ) upon cardiac morphology in professional athletes. This is important as it is widely recognised that LV dimensions are influenced by body anthropometry. 9 10 Pluim et al 2 was the first to recognise the importance of BSA when undertaking preparticipation screening, suggesting that the probability of falsepositive HCM identification would be exacerbated in athletes with a BSA>2 m 2 . Basketball, handball and volleyball are three such sports whereby some male athletes may exceed the stereotypical anthropometry for an athlete; with heights and body mass's reaching 220 cm and 150 kg, respectively. 11 12 Magalski et al 13 electrocardiographic examination of 1959 American Football players was one of the largest studies to undertake preparticipation screening in athletes with large anthropometry (mean BSA; 2.4±0.3 m 2 ). Regrettably, only 203 American Football players received an echocardiogram following a referral due to an abnormal ECG, family history or clinical examination, with the BSA of this cohort unreported.
The aim of the present study was to investigate the cardiac structure and function in professional male athletes with extreme anthropometry (≥2.3 m 2 ), to confirm if the established upper limits of physiological cardiac adaptation to intensive and sustained physical activity are applicable for this unique population.
METHODS
Ethical approval was obtained from the Shafallah Medical Genetics Centre ethics committee, with all athletes completing informed consent.
Participants 836 asymptomatic professional male athletes (age 25±8 years), exercising ≥6 h/week in 15 high-intensity intermittent sporting disciplines (eg, Soccer, n=586; basketball, n=75; volleyball, n=41 and handball, n=35) presented at our institution for preparticipation cardiac screening ( 
Physical examination
The physical examination was based on the European Society of Cardiology (ESC) sport's cardiology section consensus statement. 11 Players completed the questionnaire regarding family history and personal symptoms in collaboration with an Arabic-speaking, French-speaking or English-speaking Sports Medicine Physician and Nurse. Measurement of height (SECA 264, Hamburg, Germany), body mass (Detecto 6129KGM, Missouri, USA), brachial artery blood pressure (GE Dinamap Pro 400V2, New York, USA) in the supine position (both left and right arms) after a period of 5 min rest, precordial auscultation in supine and standing positions, and assessment for any physical characteristics of Marfan's syndrome were undertaken by a Sports Medicine Physician.
Resting 12-lead ECG
A standard 12-lead ECG was obtained using a GE Mac 5500 (New York, USA) after a period of 5 min rest in the supine position. All ECG's were reported independently by two experienced investigators (OS and MW) using the recent 2010 ESC recommendations for interpretation of 12-lead electrocardiogram in the athlete, 17 with third opinions sought from two international cardiologists (SS and FC) for difficult cases.
Echocardiography
A two-dimensional (2D), M-mode and Doppler and tissue Doppler echocardiographic examination was performed in the left lateral decubitas position by a consultant cardiologist using a commercially available ultrasound system (Philips, USA). Images of the heart were obtained in the standard parasternal long-axis and short-axis and apical four-chamber planes, as previously described, 18 in order to identify subtle focal regions of abnormal LV hypertrophy. The LV wall thickness was measured from 2D short-axis views in end-diastole, with the greatest measurement within the LV wall defined as the maximal wall thickness. M-mode echocardiograms derived from 2D images in the parasternal long axis were used for the measurement of LV end-diastolic diameter (LVIDd) and LV end-systolic (LVIDs) dimensions, left atrial diameter and aortic root diameter according to American Society of Echocardiography standards, 19 with LV volumes (diastolic and systolic) derived using Simpson's biplane methodology. Left ventricular mass was calculated using the formula of Devereux. 20 Three to five consecutive measurements were taken, and the average was calculated. Left ventricular diastolic function was assessed using pulsed-wave Doppler recordings from apical four-chamber orientations. A 4 mm sample volume was placed at the tips of the mitral leaflets in diastole and transmitral flow was acquired to obtain peak early (E) and atrial (A) flow velocities. All data was analysed offline and a minimum of three cardiac cycles were averaged for all indices. For the tissue Doppler assessment of E', the apical four-chamber orientation was utilised and a 2 mm sample volume was positioned at both the septal and lateral wall aspect of the mitral valve annulus ensuring the best alignment between wall motion and the ultrasound beam. The high-pass filter was bypassed and gains set to a minimal value to obtain the best signal-to-noise ratio. The nyquist limit was set between 10 and 35 cm/s. Peak early diastolic (E') tissue myocardial velocity was recorded and E/E' was calculated.
Criteria for consideration of the diagnosis of pathological LVH in athletes
On the basis of previous publications and our own experience of an athlete's heart, athletes with an LV wall thickness >12 mm were considered to have LVH. 7 21 22 Athletes with LVH and a relatively non-dilated LV in terms of athletic training (<56 mm) 23 in association with any one of the following were considered to have findings that could be consistent with pathological LVH rather than physiological hypertrophy: (1) impaired diastolic function; 24 (2) enlarged left atrial diameter >45 mm in athletes 30 cardiopulmonary exercise test 31 32 and cardiac MRI 33 to evaluate the broader phenotype of common cardiomyopathic processes such as HCM and arrhythmogenic right ventricular cardiomyopathy, in addition to assessing the risk of SCD. 34 
Statistical analysis
All data were presented as mean±SD and (range), and analysed using SPSS (Statistical Package for Social Sciences 17, Illinois, USA). Data were analysed using a two-way between-subjects analysis of variance, with pair-wise comparisons, used to identify any significant differences in athlete anthropometrics and echocardiographic characteristics between the three BSA groups, together with athlete anthropometrics and echocardiographic characteristics between Black African, West-Asian and Caucasian ethnicity in the >2.3 m 2 BSA group. Relationships between data indices of echocardiographic measures of cardiac structure and function against the athletes BSA together with their resting systolic blood pressure were examined via Pearson's product-moment correlation analysis. A p value <0.05 was considered significant.
RESULTS
None of the athletes experienced angina, breathlessness disproportionate to the amount of exercise performed, or exertional syncope. The diagnosis of HCM was excluded by echocardiography in 819 (98%) on the basis of an LV wall thickness <12 mm, absence of systolic anterior motion of the anterior mitral valve leaflet causing LV outflow obstruction and normal diastolic function.
Athletes with an LV wall thickness >12 mm (LVH)
Of the 836 athletes, 17 (2%) showed a maximal LV wall thickness exceeding 12 mm and were considered to have LVH. 23 Twelve (12%) of these athletes demonstrating LVH came from the >2.3 m 2 BSA cohort, compared with just 3 (1.2%) and 2 (0.4%) from Groups 2 and 3, respectively. All 17 athletes with LVH had an appropriate (≥45 mm) LV chamber dimension (mean 56±4 mm, (range 49-63)), normal systolic and diastolic function, an enlarged left atrial diameter and no systolic anterior motion of the anterior mitral valve leaflet or LV outflow obstruction.
Athletes with an LVH >12 mm and an abnormal ECG
Of the 17 athletes with LVH, only 2 (0.2%) demonstrated a wall thickness that exceeded 13 mm (table 2; athletes 1 and 2). However, both athletes also demonstrated ECG's highly suspicious of HCM ( figure 1A,B) . Following extensive further investigation, both athletes were diagnosed with a cardiomyopathy and were eventually disqualified from competitive sport. Both athletes were removed from any further group analysis.
Athletes with other cardiac abnormalities on ECG and echocardiography
One further athlete (table 2; athlete 3) was diagnosed with a mild variant of apical HCM, due to disproportionally thickened apical segments of the basal and septal walls upon cardiac MRI, following an abnormal ECG ( figure 1C ) but normal echocardiogram (maximal basal LV wall thickness of 8 mm). This athlete was removed from any further group analysis. Four asymptomatic athletes without cardiac murmur were found to have trivial valve regurgitation (one mitral, one aortic and two tricuspid), not requiring further investigation after echocardiography. Finally, one asymptomatic player had an aortic root 
DISCUSSION
The main finding of the current study was that the upper normal limits for maximal LV dimensions in professional male athletes with extreme anthropometric characteristics (BSA>2.3 m 2 ) remains 14 mm for maximal wall thickness and 65 mm for LV internal diameter during diastole. Furthermore, Figure 1 (A)-(C) Twelve-lead ECG and cardiac magnetic resonance images of two athletes (1 and 2) with a maximal wall thickness greater than 13 mm, and one athlete (3) with a maximal wall thickness of 8.2 mm on echocardiography, yet apical segments do not show normal tapering pattern and are disproportionately thickened on CMR imaging. Arrow (athlete 2) points to localised fibrosis of the septal wall at the mid-cavity level. This figure is only reproduced in colour in the online version.
for those athletes with the largest BSA's, Black African ethnicity was associated with larger cardiac dimensions than either West-Asian or Caucasian ethnicity. Finally, in a sample of 836 athletes, 3 were diagnosed with a cardiomyopathy; 0.4% prevalence rate that in all cases, the ECG was vital for the initial identification and eventual diagnosis of the disease.
From four large-scale echocardiographic studies examining a total of 5053 elite athletes, 4 7 8 35 only 134 athletes (2.7%) demonstrated a maximal wall thickness greater than 12 mm, with only a further 27 athletes (0.5%) presenting LVH>13 mm. However, out of these 5053 athletes the largest end of range BSA's in all four studies varied from 2.26 to 2.29 m ). Only one athlete from this cohort demonstrated LVH>13 mm, but he also exhibited a particular abnormal ECG suggestive of an inherited cardiac disease, and was eventually diagnosed with HCM via cardiac magnetic resonance. Of the remaining 99 asymptomatic athletes, 12 (12%) had a wall thickness greater than 12 mm and 18 (18%) had an LVIDd greater than 60 mm. However, in the presence of a normal ECG, absence of systolic anterior motion of the anterior mitral valve leaflet causing LV outflow obstruction, an appropriately dilated LV, and normal diastolic function, a diagnosis of HCM was excluded in all athletes. This study suggests that irrespective of an athlete's enlarged BSA, the upper limit of physiological maximal wall thickness remains in the 13-16 mm range. Indeed, our data support the more conservative approach limits suggested by Whyte et al 4 such that regardless of extreme body anthropometry, the physiological upper normal limits of LV wall thickness and LVIDd are 14 and 65 mm, respectively.
Despite being referred for echocardiography due to a clinical suspicion of possible cardiac disease based on an abnormal ECG, family history or clinical evaluation, two studies are worthy of mention that support our data in 'big' athletes. It is well recognised that little account of body size is taken in the determination of 'apparently normal' cardiac dimensions in adult athletes, even though allometric scaling in the paediatric population is routine practice. 36 Despite the strong relationships between BSA and multiple LV measures in the current study, absolute upper normal limits are still clinically relevant. It may be that scaling, via an appropriate method and scaling variable, maybe be of more clinical value in those athletes with smaller BSA's.
Recent data suggest that an athlete's ethnic origin may have a significant impact on their cardiovascular response to exercise. 13 35 37 Despite no significant difference in BSA between ethnicities in the >2.3 m 2 cohort of athletes, Black African athletes presented significantly greater wall thicknesses, and resultant LV masses, than West-Asian and Caucasian athletes. It should be noted that regardless of ethnicity and the extreme BSA of this cohort, the established upper limits of cardiac structure and function are applicable to all three ethnicities. Previous data from our group have demonstrated that a minority (3%) of Black athletes (mean BSA 2.1 m 2 ; 9 from 300) may present physiological LVH≥15 mm. 34 The present data set of 219 Black African athletes from a broad range of BSA's did not find an athlete with a normal ECG presenting a maximal wall thickness greater than 13 mm. A limitation of the present study is that a data set of 46 Black African with a BSA>2. 39 probably accounts for the increased LVH in black athletes. Yet to date, no data have been published to confirm this postulation. Second, while professional basketball, handball and volleyball players were recruited, substantiation of the upper limits of physiological LVH is required in the small minority of athletes with extreme BSA's who compete in sports that induce the greatest amounts of cardiac remodelling; namely rowing, cycling, cross-country skiing, biathlon. Nevertheless, this will once again prove problematic for the Black African ethnicity whose participation in these endurance sports is limited.
Regardless of these limitations, our data support the clinical utility of ECG in the initial identification of athletes suspected of harbouring an inherited cardiac disease. The present study diagnosed one athlete with a mild variant of apical HCM via cardiac magnetic resonance, following an abnormal ECG suggestive of an inherited cardiac disease. This was in spite of a normal echocardiogram (maximal LV wall thickness of 8 mm). In conclusion, marked repolarisation changes, ST depression, pathological Q waves and multiple ventricular ectopic's are a great concern, even when cardiac dimensions are within accepted limits.
In conclusion, irrespective of an athlete's extreme anthropometrical dimensions and ethnicity, the physiological upper normal limits of LV wall thickness and LV internal diameter during diastole due to intensive and sustained physical activity are 14 and 65 mm, respectively. Moreover, even when matched for extreme BSA (>2.3 m 2 ), Black African athletes present significantly greater wall thicknesses and resultant LV masses than Arabic and Caucasian athletes.
What this study adds ▸ Regardless of extreme body surface area (BSA), no asymptomatic athlete with a negative family history of sudden cardiac death and a normal ECG presented a maximal wall thickness >14 mm. ▸ Established upper limits for physiological cardiac hypertrophy of 14 mm for maximal wall thickness and 65 mm for left ventricular internal diameter during diastole are appropriate, irrespective of an athlete's BSA. ▸ We identified one athlete with a cardiomyopathy with normal wall thicknesses on echocardiography but abnormal cardiac magnetic resonance. The ECG remains key and should guide follow-up management. Marked repolarisation changes, ST depression, pathological Q waves and multiple ventricular ectopic's are a great concern, even when cardiac dimensions are within accepted limits on echocardiography.
